Ads 468x60px


PCPPI to provide free vaccines to all its employees joins the private sector in Dose of Hope initiative.

Pepsi-Cola Products Philippines Inc. (PCPPI),—the exclusive manufacturer of PepsiCo beverages in the country—announced today that it will provide free COVID-19 vaccines to all its employees who will voluntarily receive them. The company purchased the vaccines as part of the tripartite agreement between the private sector, the government and vaccine manufacturers.

Photo credit: PCPPI Facebook page

“Providing free vaccines is essential to a healthy and safe working environment at PCPPI. The inoculation will be voluntary but we highly encourage everyone to be vaccinated. This is to show gratitude to our employees who have all worked hard during the pandemic,” said President and Chief Executive Officer (CEO) Frederick D. Ong.

The vaccination program is part of “Dose of Hope” initiative led by Presidential Adviser for Entrepreneurship Joey Concepcion. The program already purchased 17 million doses of COVID-19 vaccines from AstraZeneca. Set delivery date of vaccines for the company will be on the 3rd quarter of this year.

“PCPPI participated in the ‘Dose of Hope’ initiative for faster vaccine rollout. This is our way of supporting the private sector’s goal of reviving the economy and the government’s efforts in controlling COVID,” Ong added. PCPPI also held a virtual learning session on COVID-19 Vaccination for its employees. Dr. Iris Radev, MD from Ocean Medical Clinic in British Columbia, Canada, facilitated the online event. With close to 300 attendees, the session aimed to encourage vaccination. "Our employees need to know the right information on COVID-19 vaccines. The benefits of inoculation definitely outweighs the risks and fears we have," added Vibes Cheong, Senior Vice President for Human Resources and Corporate Affairs.

PPCPI manufactures and sells well-known PepsiCo beverages brands such as Pepsi-Cola, Mountain Dew, 7-Up, Mirinda, Mug, Gatorade, Aquafina, Premier, Sting, Tropicana and Lipton.

0 replies: